share_log

昊海生物科技(06826.HK):7月通过集中竞价交易方式累计回购26.52万股A股

Haohai Biotec (06826.HK): In July, it accumulated repurchased 0.2652 million A-shares through centralized bidding trading.

Gelonghui Finance ·  Aug 1 05:39

On July 2024, haohai biotec (06826.HK) announced that the company has accumulated the repurchase of 0.2652 million A-shares of the company through centralized competitive bidding, accounting for 0.11% of the total share capital at the highest fill price of HKD 62.90 per share and the lowest fill price of HKD 58.45 per share. The total transaction amount is RMB 16.1091 million (excluding stamp duty, transaction commission and other transaction costs). As of July 31, 2024, the company has accumulated the repurchase of 2.0157 million A-shares through centralized competitive bidding.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment